• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球在心血管疾病预防方面取得的进展。

Global progress in prevention of cardiovascular disease.

作者信息

Mendis Shanthi

机构信息

Geneva Learning Foundation, Geneva, Switzerland.

出版信息

Cardiovasc Diagn Ther. 2017 Apr;7(Suppl 1):S32-S38. doi: 10.21037/cdt.2017.03.06.

DOI:10.21037/cdt.2017.03.06
PMID:28529920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5418214/
Abstract

Although there is measurable global progress in prevention of cardiovascular disease (CVD), it has been highly uneven and inadequate, particularly in low- and middle-income countries. Voluntary global targets have helped to galvanize attention, resources and accountability on tobacco use, harmful use of alcohol, unhealthy diet and physical inactivity which are the major behavioural drivers of CVD. Many obstacles and challenges continue to impede the progress of cardiovascular prevention. The inclusion of noncommunicable diseases (NCDs) in the sustainable development agenda as a specific target, offers an unprecedented opportunity to further advance the global progress of cardiovascular prevention. In order to seize this opportunity, a paradigm shift is required in the way key challenges to cardiovascular prevention are addressed. Such an approach must provide leadership for intersectoral policy coherence, identify effective means of tackling commercial determinants of behavioural risk factors, use rights based arguments, enhance public engagement and ensure accountability.

摘要

尽管在预防心血管疾病(CVD)方面全球取得了可衡量的进展,但进展极不均衡且不充分,在低收入和中等收入国家尤其如此。自愿性全球目标有助于激发对烟草使用、有害使用酒精、不健康饮食和身体活动不足的关注、资源投入和问责制,而这些是心血管疾病的主要行为驱动因素。许多障碍和挑战继续阻碍心血管疾病预防工作的进展。将非传染性疾病(NCDs)纳入可持续发展议程作为一项具体目标,为进一步推动全球心血管疾病预防工作的进展提供了前所未有的机遇。为抓住这一机遇,应对心血管疾病预防关键挑战的方式需要进行范式转变。这种方法必须为部门间政策协调提供领导,确定应对行为风险因素商业决定因素的有效手段,运用基于权利的论据,加强公众参与并确保问责制。

相似文献

1
Global progress in prevention of cardiovascular disease.全球在心血管疾病预防方面取得的进展。
Cardiovasc Diagn Ther. 2017 Apr;7(Suppl 1):S32-S38. doi: 10.21037/cdt.2017.03.06.
2
Intersectoral Policy Priorities for Health卫生领域的跨部门政策优先事项
3
Health in the sustainable development goals: ready for a paradigm shift?可持续发展目标中的健康:准备好迎接范式转变了吗?
Global Health. 2015 Mar 21;11:13. doi: 10.1186/s12992-015-0098-8.
4
Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.健康人群与健康利润?构建一个用于管控非传染性疾病商业决定因素的概念框架并确定降低风险暴露的选项。
Global Health. 2017 Jun 15;13(1):34. doi: 10.1186/s12992-017-0255-3.
5
India's NCD strategy in the SDG era: are there early signs of a paradigm shift?印度在可持续发展目标时代的非传染性疾病战略:是否有范式转变的早期迹象?
Global Health. 2018 Apr 25;14(1):39. doi: 10.1186/s12992-018-0357-6.
6
Progress and challenges in achieving noncommunicable diseases targets for the sustainable development goals.实现可持续发展目标中关于非传染性疾病目标的进展与挑战
FASEB Bioadv. 2021 Apr 29;3(8):563-568. doi: 10.1096/fba.2020-00117. eCollection 2021 Aug.
7
Addressing the Global Burden of Cardiovascular Diseases; Need for Scalable and Sustainable Frameworks.解决全球心血管疾病负担;需要可扩展和可持续的框架。
Glob Heart. 2022 Jul 29;17(1):48. doi: 10.5334/gh.1139. eCollection 2022.
8
Addressing NCDs: A unifying agenda for sustainable development.应对非传染性疾病:可持续发展的统一议程。
Glob Public Health. 2018 Sep;13(9):1152-1157. doi: 10.1080/17441692.2017.1394481. Epub 2017 Oct 28.
9
Non-communicable disease prevention in Nepal: systemic challenges and future directions.尼泊尔的非传染性疾病预防:系统性挑战与未来方向。
Glob Health Promot. 2019 Sep;26(3):94-97. doi: 10.1177/1757975917720800. Epub 2017 Sep 1.
10
Tuberculosis结核病

引用本文的文献

1
Polymorphic and Expressional Analysis of Genes and in Cardiovascular Patients Using Conventional and qPCR Approach.使用传统方法和定量聚合酶链反应方法对心血管疾病患者的基因进行多态性和表达分析。
Int J Hypertens. 2025 Aug 25;2025:7379376. doi: 10.1155/ijhy/7379376. eCollection 2025.
2
Development of Iranian clinical practice guidelines: An experience in cardiovascular diseases-A policy brief.伊朗临床实践指南的制定:心血管疾病领域的经验——政策简报
J Res Med Sci. 2025 Mar 29;30:16. doi: 10.4103/jrms.jrms_617_24. eCollection 2025.
3
A Positive Feedback Loop Between CXCL16 and the Inflammatory Factors IL-17A and TGF- Promotes Large Artery Atherosclerosis by Activating the STAT3/NF-B Pathway.CXCL16与炎性因子IL-17A和转化生长因子之间的正反馈回路通过激活STAT3/NF-κB途径促进大动脉粥样硬化。
Cardiovasc Ther. 2025 Mar 24;2025:2973633. doi: 10.1155/cdr/2973633. eCollection 2025.
4
Exposure to specific polyfluoroalkyl chemicals is associated with cardiovascular disease in US adults: a population-based study.美国成年人接触特定多氟烷基化学品与心血管疾病有关:一项基于人群的研究。
Front Cardiovasc Med. 2025 Jan 9;11:1487956. doi: 10.3389/fcvm.2024.1487956. eCollection 2024.
5
Development of the first Iranian clinical practice guidelines for the diagnosis, treatment, and secondary prevention of acute coronary syndrome.首部伊朗急性冠状动脉综合征诊断、治疗及二级预防临床实践指南的制定。
J Res Med Sci. 2024 Jul 11;29:32. doi: 10.4103/jrms.jrms_851_23. eCollection 2024.
6
Hypoxic Therapy as a New Therapeutic Modality for Cardiovascular Benefit: A Mini Review.低氧疗法作为一种对心血管有益的新治疗方式:一篇综述短文
Rev Cardiovasc Med. 2022 Apr 28;23(5):161. doi: 10.31083/j.rcm2305161. eCollection 2022 May.
7
Quality appraisal and descriptive analysis of clinical practice guidelines for self-managed non-pharmacological interventions of cardiovascular diseases: a systematic review.对心血管疾病自我管理非药物干预临床实践指南的质量评价和描述性分析:系统评价。
J Transl Med. 2024 Feb 29;22(1):215. doi: 10.1186/s12967-024-04959-5.
8
World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update.世界心脏联盟心血管疾病二级预防路线图:2023年更新版
Glob Heart. 2024 Jan 22;19(1):8. doi: 10.5334/gh.1278. eCollection 2024.
9
Examining disparities in cardiovascular disease prevention strategies and incidence rates between urban and rural populations: insights from Kazakhstan.探讨哈萨克斯坦城乡人口在心血管疾病预防策略和发病率方面的差异。
Sci Rep. 2023 Nov 28;13(1):20917. doi: 10.1038/s41598-023-47899-8.
10
A multilevel and multicenter assessment of health care system capacity to manage cardiovascular diseases in Africa: a baseline study of the Ghana Heart Initiative.一项针对非洲心血管疾病管理的医疗体系能力的多层次、多中心评估:加纳心脏倡议的基线研究。
BMC Cardiovasc Disord. 2023 Aug 24;23(1):421. doi: 10.1186/s12872-023-03430-5.

本文引用的文献

1
The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation.“25×25”的核心目标:实现减少全球及区域心血管疾病和中风过早死亡的目标:美国心脏协会和世界心脏联盟的一项建模研究
Circulation. 2016 Jun 7;133(23):e674-90. doi: 10.1161/CIR.0000000000000395. Epub 2016 May 9.
2
Modelling the impact of alcohol consumption on cardiovascular disease mortality for comparative risk assessments: an overview.为进行比较风险评估而模拟酒精消费对心血管疾病死亡率的影响:概述
BMC Public Health. 2016 Apr 28;16:363. doi: 10.1186/s12889-016-3026-9.
3
Regional contributions of six preventable risk factors to achieving the 25 × 25 non-communicable disease mortality reduction target: a modelling study.六个可预防风险因素对实现 25×25 非传染性疾病死亡率降低目标的区域贡献:建模研究。
Lancet Glob Health. 2015 Dec;3(12):e746-57. doi: 10.1016/S2214-109X(15)00179-5. Epub 2015 Oct 20.
4
Contributions of risk factors and medical care to cardiovascular mortality trends.风险因素和医疗保健对心血管疾病死亡率趋势的影响
Nat Rev Cardiol. 2015 Sep;12(9):508-30. doi: 10.1038/nrcardio.2015.82. Epub 2015 Jun 16.
5
Health in the sustainable development goals: ready for a paradigm shift?可持续发展目标中的健康:准备好迎接范式转变了吗?
Global Health. 2015 Mar 21;11:13. doi: 10.1186/s12992-015-0098-8.
6
Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys.1990 年和 2010 年全球、区域和国家的膳食脂肪和油消费水平:包括 266 个国家具体营养调查的系统分析。
BMJ. 2014 Apr 15;348:g2272. doi: 10.1136/bmj.g2272.
7
Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality.2003年至2011年英格兰的减盐情况:其与血压、中风及缺血性心脏病死亡率的关系。
BMJ Open. 2014 Apr 14;4(4):e004549. doi: 10.1136/bmjopen-2013-004549.
8
Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study.21 个世界地区 1980 至 2010 年缺血性心脏病死亡率的时间趋势:2010 年全球疾病负担研究。
Circulation. 2014 Apr 8;129(14):1483-92. doi: 10.1161/CIRCULATIONAHA.113.004042. Epub 2014 Feb 26.
9
Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide.1990 年和 2010 年全球、区域和国家钠摄入量:对全球 24 小时尿钠排泄和膳食调查的系统分析。
BMJ Open. 2013 Dec 23;3(12):e003733. doi: 10.1136/bmjopen-2013-003733.
10
The contributions of risk factor trends to cardiometabolic mortality decline in 26 industrialized countries.26 个工业化国家中,危险因素趋势对心血管代谢死亡率下降的贡献。
Int J Epidemiol. 2013 Jun;42(3):838-48. doi: 10.1093/ije/dyt063. Epub 2013 Jun 5.